BioWorld MedTech

April 7, 2011

Emerge sees a need for line of generic orthopedic devices

A new medical device company has emerged with the goal of targeting the $2 billion orthopedic trauma market with the industry's first line of high-quality generic implants and instruments. (Medical Device Daily) Read More

VisualSonics developing new photoacoustics imaging tool

International report: Volcano cleared to market PrimeWire Prestige in Japan

Shuren says start date of new harmonization body uncertain

Deals roundup: LabCorp to acquire OC shares for $85 million

MDD's food for med-tech thought

Agreements/contracts: GE partners with TomTec to 'enhance patient care'

Court Report: Hospital to pay $1.9M to settle Medicare fraud charges

Med-Tech Notes

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...